Hemp, Inc.’s Creative Visionary Consultant, Bruce Perlowin, to be Interviewed Live on the Quantum Energy, Health, and Information Call Today

LAS VEGAS, NV, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hemp, Inc. (OTC PINK: HEMP) today announced that its Creative Visionary Consultant, Bruce Perlowin, will take center stage in a live broadcast with the Quantum Energy, Health, and Information Call on Monday, September 18, 2023, at 12:00 pm EST. Tune in to gain valuable insights on how Hemp, Inc.’s CBD health and wellness product line can be an asset to your daily health routine. Simply dial [phone] (no pin needed).

In anticipation of this upcoming broadcast, Bruce Perlowin, CVC, expressed his sentiments, saying,

"Quite frankly, every time I walk into a CBD store, I’m embarrassed by the low dosage of CBD in competitor products. There’s a stark contrast between our highly potent, highly absorbable CBD product and most other products on the market." Perlowin’s sentiments underscored the remarkable quality and potency of Hemp, Inc.'s CBD offerings and emphasized the company's commitment to delivering premium, effective CBD solutions to consumers.

There are many products sold in the United States as supplements or nutraceuticals that contain beneficial ingredients, just to have on the label. Unfortunately, most contain a fairy dust sprinkling of the beneficial ingredients and as a result, do not work beyond the placebo effect. Hemp, Inc.’s analysis of published clinical trials showed that entry-level results began around 150 milligrams of CBD and 50 milligrams of CBG. Some results happened at lower levels, but not consistently.

The Company’s testing showed 250 milligrams of CBD and 83.34 milligrams of CBG were consistent and not improved by additional CBD or CBG. There are thirty, one-milliliter servings in a one-ounce bottle. 30 x 250 = 7,500 milligrams of CBD. 30 x 83.34 = 2,500 milligrams CBG. Tinctures with 3,000 milligrams of CBD, 100 milligrams per serving, commonly cost between $82 and $132 per bottle. We think that is in the fairy dust arena.

There have also been in vitro (in glass) studies showing that CBDA, CBGA, and CBD stop the Coronavirus. However, the concentration of cannabinoids that worked in vitro cannot be obtained in vivo (with the living). Thus, we make no medical claims at all.

Hemp, Inc.’s product line includes CBD, CBDA, CBG, CBGA, and CBN, derived from hemp and known for their therapeutic properties. Hemp, Inc. distinguishes itself by using pharmaceutical-grade beta-cyclodextrin in combination with cannabinoids for rapid absorption and efficacy. Notably, their CBD/CBG coffee enhancer is highly potent, rapidly absorbed, and competitively priced, offering consumers a premium coffee experience.